RecruitingPhase 2Phase 3NCT03937661

Autologous Platelet-Rich Plasma Intra-ovarian Infusion in Poor Responders

Investigating Improvement of Ovarian Function Following Autologous PRP Intra-ovarian Infusion in Poor Responders

Sponsor

Genesis Athens Clinic

Enrollment

100 participants

Start Date

May 6, 2019

Study Type

INTERVENTIONAL

Conditions

Infertility, Female Ovary; Anomaly

Summary

Autologous PRP intra ovarian infusion may improve ovarian response, patients' hormonal profile as well as fresh embryo transfer (ET)-ICSI cycles' outcome in patients presenting with Poor Ovarian Response (POR).

Eligibility

Sex: FEMALEMin Age: 35 YearsMax Age: 47 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a biological treatment called PRP and a biological treatment called Placebo for people with infertility, female and ovary; anomaly. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 35 Years to 47 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.